Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Letter by Delmas et al Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".

Delmas C, Laine M, Bonello L.

Circulation. 2019 Sep 10;140(11):e555-e556. doi: 10.1161/CIRCULATIONAHA.119.041272. Epub 2019 Sep 9. No abstract available.

PMID:
31498693
2.

Using an Impella device to reverse refractory cardiac arrest and enable efficient coronary revascularisation.

Persico N, Guervilly C, Verhamme B, Bonello L.

BMJ Case Rep. 2019 Aug 10;12(8). pii: e230654. doi: 10.1136/bcr-2019-230654.

PMID:
31401583
3.

Cone-Beam CT-Assisted Ablation of Renal Tumors: Preliminary Results.

Monfardini L, Gennaro N, Della Vigna P, Bonomo G, Varano G, Maiettini D, Bonello L, Solbiati L, Orsi F, Mauri G.

Cardiovasc Intervent Radiol. 2019 Dec;42(12):1718-1725. doi: 10.1007/s00270-019-02296-5. Epub 2019 Jul 31.

PMID:
31367773
4.

Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome.

Laine M, Panagides V, Frère C, Cuisset T, Gouarne C, Jouve B, Thuny F, Paganelli F, Alessi MC, Mancini J, Bonello L.

J Thromb Haemost. 2019 Dec;17(12):2188-2195. doi: 10.1111/jth.14592. Epub 2019 Jul 27.

PMID:
31351022
5.

HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.

Griggio V, Vitale C, Todaro M, Riganti C, Kopecka J, Salvetti C, Bomben R, Dal Bo M, Magliulo D, Rossi D, Pozzato G, Bonello L, Marchetti M, Omedè P, Kodipad AA, Laurenti L, Del Poeta G, Mauro FR, Bernardi R, Zenz T, Gattei V, Gaidano G, Foà R, Massaia M, Boccadoro M, Coscia M.

Haematologica. 2019 Jul 9. pii: haematol.2019.217430. doi: 10.3324/haematol.2019.217430. [Epub ahead of print]

6.

Is there still a role for the intra-aortic balloon pump in the management of cardiogenic shock following acute coronary syndrome?

Leurent G, Auffret V, Pichard C, Laine M, Bonello L.

Arch Cardiovasc Dis. 2019 Dec;112(12):792-798. doi: 10.1016/j.acvd.2019.04.009. Epub 2019 Jun 24. Review.

PMID:
31248830
7.

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.

Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12. Review.

PMID:
31202949
8.

Letter by Laine et al Regarding Article, "Antithrombotic Agents: New Directions in Antithrombotic Therapy".

Laine M, Canault M, Bonello L.

Circ Res. 2019 Jun 7;124(12):e117-e118. doi: 10.1161/CIRCRESAHA.119.315213. Epub 2019 Jun 6. No abstract available.

PMID:
31170051
9.

An Unusual Acute Coronary Syndrome Due to a Septic Embolism: A Case Presentation and Review of Revascularization Strategies.

Panagides V, Laine M, Paganelli F, Bonello L.

J Invasive Cardiol. 2019 Jun;31(6):E148-E153. Review.

10.

Response to the letter to the editor: anticoagulant activity of bivalirudin.

Laine M, Paganelli F, Bonello L.

Expert Opin Pharmacother. 2019 Aug;20(11):1415. doi: 10.1080/14656566.2019.1616427. Epub 2019 May 15. No abstract available.

PMID:
31090465
11.

Letter by Bonello et al Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".

Bonello L, Laine M, Lemesle G.

Circulation. 2019 May 14;139(20):e959-e960. doi: 10.1161/CIRCULATIONAHA.118.037810. No abstract available.

PMID:
31082298
12.

Dynamic iron status after acute heart failure.

Sportouch L, Cautela J, Resseguier N, Pinto J, Ammar C, Gaubert M, Barraud J, Peyrol M, Laine M, Bonello L, Yvorra S, Paganelli F, Thuny F.

Arch Cardiovasc Dis. 2019 Jun - Jul;112(6-7):410-419. doi: 10.1016/j.acvd.2019.02.002. Epub 2019 Apr 18.

PMID:
31006624
13.

Design and preliminary results of FRENSHOCK 2016: A prospective nationwide multicentre registry on cardiogenic shock.

Delmas C, Puymirat E, Leurent G, Elbaz M, Manzo-Silberman S, Bonello L, Gerbaud E, Bataille V, Levy B, Lamblin N, Bonnefoy E, Henry P, Roubille F; FRENSHOCK investigators.

Arch Cardiovasc Dis. 2019 May;112(5):343-353. doi: 10.1016/j.acvd.2019.02.001. Epub 2019 Apr 11.

14.

Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.

Blin P, Dureau-Pournin C, Benichou J, Bonello L, Dallongeville J, Danchin N, Falissard B, Thomas-Delecourt F, Jové J, Lassalle R, Droz C, Moore N.

Atherosclerosis. 2019 Feb;281:98-106. doi: 10.1016/j.atherosclerosis.2018.11.037. Epub 2018 Dec 7.

PMID:
30658197
15.

Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction registries.

Puymirat E, Bonaca M, Fumery M, Tea V, Aissaoui N, Lemesles G, Bonello L, Ducrocq G, Cayla G, Ferrières J, Schiele F, Simon T, Danchin N; FAST-MI investigators.

Clin Cardiol. 2019 Feb;42(2):227-234. doi: 10.1002/clc.23131. Epub 2018 Dec 27.

16.

Bivalirudin during percutaneous coronary intervention in acute coronary syndromes.

Laine M, Lemesle G, Dabry T, Panagides V, Peyrol M, Paganelli F, Bonello L.

Expert Opin Pharmacother. 2019 Feb;20(3):295-304. doi: 10.1080/14656566.2018.1551361. Epub 2018 Dec 4. Review.

PMID:
30513232
17.

OCT Analysis of Very Early Strut Coverage of the Synergy Stent in Non-ST Segment Elevation Acute Coronary Syndrome Patients.

Laine M, Dabry T, Combaret N, Motreff P, Puymirat E, Paganelli F, Thuny F, Cautela J, Peyrol M, Mancini J, Lemesle G, Bonello L.

J Invasive Cardiol. 2019 Jan;31(1):10-14. Epub 2018 Nov 11.

18.

P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes.

Bonello L, Angiolillo DJ, Aradi D, Sibbing D.

Circulation. 2018 Oct 9;138(15):1582-1596. doi: 10.1161/CIRCULATIONAHA.118.032078. Review.

PMID:
30354508
19.

Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device.

Peyrol M, Cautela J, Salaun E, Miola C, Franceschi F, Thuny F, Pinto J, Laine M, Maximovitch A, Paganelli F, Armero S, Bonello L.

Heart Lung Circ. 2019 Nov;28(11):1683-1688. doi: 10.1016/j.hlc.2018.08.022. Epub 2018 Sep 27.

PMID:
30301672
20.

Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease.

Bonello L, Laine M, Lemesle G, Puymirat E, Dabry T, Thuny F, Paganelli F, Aradi D, Frere C, Burtey S, Sibbing D, Mancini J.

Thromb Haemost. 2018 Oct;118(10):1839-1846. doi: 10.1055/s-0038-1669426. Epub 2018 Sep 20.

PMID:
30235475
21.

Doppler echocardiography for assessment of systemic vascular resistances in cardiogenic shock patients.

Gaubert M, Resseguier N, Thuny F, Paganelli F, Cautela J, Pinto J, Ammar C, Laine M, Bonello L.

Eur Heart J Acute Cardiovasc Care. 2018 Aug 20:2048872618795514. doi: 10.1177/2048872618795514. [Epub ahead of print]

PMID:
30124051
22.

Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock.

Gaubert M, Marlinge M, Kerbaul F, Resseguier N, Laine M, Cautella J, Cordier C, Colomb B, Kipson N, Thuny F, Mottola G, Fenouillet E, Ruf J, Paganelli F, Guieu R, Bonello L.

Crit Care Med. 2018 Sep;46(9):e874-e880. doi: 10.1097/CCM.0000000000003252.

PMID:
29923934
24.

Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters.

Debry N, Kone P, Vincent F, Lemesle G, Delhaye C, Schurtz G, Spillemaeker H, Porouchani S, Coisne A, Auffray JL, Sudre A, Lamblin N, Bonello L, Van Belle E.

EuroIntervention. 2018 Aug 3;14(5):e519-e525. doi: 10.4244/EIJ-D-18-00029.

25.

Specific Pharmacological Profile of A2A Adenosine Receptor Predicts Reduced Fractional Flow Reserve in Patients With Suspected Coronary Artery Disease.

Paganelli F, Resseguier N, Marlinge M, Laine M, Malergue F, Kipson N, Armangau P, Pezzoli N, Kerbaul F, Bonello L, Mottola G, Fenouillet E, Guieu R, Ruf J.

J Am Heart Assoc. 2018 Apr 13;7(8). pii: e008290. doi: 10.1161/JAHA.117.008290.

26.

Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.

Gaubert M, Marlinge M, Alessandrini M, Laine M, Bonello L, Fromonot J, Cautela J, Thuny F, Barraud J, Mottola G, Rossi P, Fenouillet E, Ruf J, Guieu R, Paganelli F.

Purinergic Signal. 2018 Jun;14(2):191-199. doi: 10.1007/s11302-018-9604-9. Epub 2018 Apr 6.

27.

Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.

Grimaldi-Bensouda L, Danchin N, Dallongeville J, Falissard B, Furber A, Cottin Y, Bonello L, Morel O, Leclercq F, Puymirat E, Ghanem F, Delarche N, Benichou J, Abenhaim L; PGRx-Acute Coronary Syndrome Study Group.

Heart. 2018 Oct;104(19):1583-1592. doi: 10.1136/heartjnl-2017-312534. Epub 2018 Mar 13.

PMID:
29535227
28.

To Have and Have Not: Intrinsic Platelet Hyperreactivity?

Laine M, Frere C, Bonello L.

J Am Heart Assoc. 2018 Mar 3;7(5). pii: e008750. doi: 10.1161/JAHA.118.008750. No abstract available.

29.

Impact of the time-to-treatment concept on the outcome of acute heart failure: A pilot study.

Trevisan L, Cautela J, Resseguier N, Baptiste F, Pinto J, Escudier M, Laine M, Roch A, Peyrol M, Barraud J, Paganelli F, Bonello L, Thuny F.

Arch Cardiovasc Dis. 2018 Apr;111(4):270-275. doi: 10.1016/j.acvd.2017.11.005. Epub 2018 Feb 28.

30.

Temporal trends in clinical characteristics and management according to sex in patients with cardiogenic shock after acute myocardial infarction: The FAST-MI programme.

Isorni MA, Aissaoui N, Angoulvant D, Bonello L, Lemesle G, Delmas C, Henry P, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat É; FAST-MI investigators.

Arch Cardiovasc Dis. 2018 Oct;111(10):555-563. doi: 10.1016/j.acvd.2018.01.002. Epub 2018 Feb 22.

31.

Great expectations.

Lemesle G, Laine M, Pankert M, Puymirat E, Bonello L.

Lancet. 2018 Jan 27;391(10118):306. doi: 10.1016/S0140-6736(18)30096-5. Epub 2018 Jan 31. No abstract available.

PMID:
29413039
32.

Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial.

Lemesle G, Laine M, Pankert M, Puymirat E, Cuisset T, Boueri Z, Maillard L, Armero S, Cayla G, Bali L, Motreff P, Peyre JP, Paganelli F, Kerbaul F, Roch A, Michelet P, Baumstarck K, Bonello L.

Clin Cardiol. 2018 Jan;41(1):5-12. doi: 10.1002/clc.22852. Epub 2018 Jan 22.

33.

Mechanical Support in Cardiogenic Shock Complicating Acute Coronary Syndrome: Ready for Prime Time?

Schurtz G, Laine M, Delmas C, Kerbaul F, Puymirat E, Lemesle G, Bonello L.

Curr Vasc Pharmacol. 2018;16(5):418-426. doi: 10.2174/1570161116666180116165544. Review.

PMID:
29345584
34.

Risk of Arterial Thrombosis in Cancer Patients: Which Role for Cancer Therapies Vascular Toxicities?

Frere C, Martin-Toutain I, Thuny F, Bonello L.

J Am Coll Cardiol. 2018 Jan 16;71(2):260. doi: 10.1016/j.jacc.2017.10.087. No abstract available.

35.

Long-term clinical outcomes in patients with cardiogenic shock according to left ventricular function: The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) programme.

Aissaoui N, Riant E, Lefèvre G, Delmas C, Bonello L, Henry P, Bonnefoy E, Schiele F, Ferrières J, Simon T, Danchin N, Puymirat E; FAST-MI investigators.

Arch Cardiovasc Dis. 2018 Nov;111(11):678-685. doi: 10.1016/j.acvd.2017.11.002. Epub 2017 Dec 28.

36.

Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation.

Gaubert M, Resseguier N, Laine M, Bonello L, Camoin-Jau L, Paganelli F.

J Thromb Haemost. 2018 Mar;16(3):465-473. doi: 10.1111/jth.13931. Epub 2018 Jan 19.

PMID:
29274198
37.

Clinical outcomes according to symptom presentation in patients with acute myocardial infarction: Results from the FAST-MI 2010 registry.

Puymirat E, Aissaoui N, Bonello L, Cayla G, Labèque JN, Nallet O, Motreff P, Varenne O, Schiele F, Ferrières J, Simon T, Danchin N; FAST-MI Investigators.

Clin Cardiol. 2017 Dec;40(12):1256-1263. doi: 10.1002/clc.22819. Epub 2017 Dec 15.

38.

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome.

Frere C, Laine M, Lemesle G, Morange PE, Paganelli F, Dignat-George F, Resseguier N, Guieu R, Camoin-Jau L, Bonello L.

Platelets. 2019;30(1):105-111. doi: 10.1080/09537104.2017.1384541. Epub 2017 Nov 27.

PMID:
29172822
39.

Research and Therapeutic Nihilisms in Chronic Kidney Disease.

Laine M, Burtey S, Puymirat E, Lemesle G, Bonello L.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2343-2344. doi: 10.1016/j.jcin.2017.08.038. No abstract available.

40.

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity.

Escudier M, Cautela J, Malissen N, Ancedy Y, Orabona M, Pinto J, Monestier S, Grob JJ, Scemama U, Jacquier A, Lalevee N, Barraud J, Peyrol M, Laine M, Bonello L, Paganelli F, Cohen A, Barlesi F, Ederhy S, Thuny F.

Circulation. 2017 Nov 21;136(21):2085-2087. doi: 10.1161/CIRCULATIONAHA.117.030571. No abstract available.

PMID:
29158217
41.

International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.

Angiolillo DJ, Rollini F, Storey RF, Bhatt DL, James S, Schneider DJ, Sibbing D, So DYF, Trenk D, Alexopoulos D, Gurbel PA, Hochholzer W, De Luca L, Bonello L, Aradi D, Cuisset T, Tantry US, Wang TY, Valgimigli M, Waksman R, Mehran R, Montalescot G, Franchi F, Price MJ.

Circulation. 2017 Nov 14;136(20):1955-1975. doi: 10.1161/CIRCULATIONAHA.117.031164. Epub 2017 Oct 30. Review.

PMID:
29084738
42.

Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach.

Trevisan L, Cautela J, Resseguier N, Laine M, Arques S, Pinto J, Orabona M, Barraud J, Peyrol M, Paganelli F, Bonello L, Thuny F.

Arch Cardiovasc Dis. 2018 Feb;111(2):109-118. doi: 10.1016/j.acvd.2017.05.006. Epub 2017 Oct 12.

43.

[Management of NSTEMI in a hospital without interventional cardiology and without use of GRACE score: Does the clinician appreciation match the GRACE score calculated retrospectively for the coronarography delay?]

Bouriche F, Yvorra S, Hassan A, Paganelli F, Bonello L, Luigi S, Attia F.

Ann Cardiol Angeiol (Paris). 2017 Nov;66(5):288-294. doi: 10.1016/j.ancard.2017.09.014. Epub 2017 Oct 10. French.

PMID:
29029775
44.

Ventricular Arrhythmia Occurrence and Compliance in Patients Treated With the Wearable Cardioverter Defibrillator Following Percutaneous Coronary Intervention.

Barraud J, Pinon P, Laine M, Cautela J, Orabona M, Koutbi L, Pinto J, Thuny F, Franceschi F, Paganelli F, Bonello L, Peyrol M.

Heart Lung Circ. 2018 Aug;27(8):984-988. doi: 10.1016/j.hlc.2017.08.022. Epub 2017 Sep 25.

PMID:
28969980
45.

Platelet Reactivity: Back to the Future?

Bonello L, Laine M, Frere C.

JACC Cardiovasc Interv. 2017 Aug 28;10(16):1618-1620. doi: 10.1016/j.jcin.2017.06.051. Epub 2017 Aug 2. No abstract available.

46.

Wearable cardioverter defibrillator: Bridge or alternative to implantation?

Barraud J, Cautela J, Orabona M, Pinto J, Missenard O, Laine M, Thuny F, Paganelli F, Bonello L, Peyrol M.

World J Cardiol. 2017 Jun 26;9(6):531-538. doi: 10.4330/wjc.v9.i6.531. Review.

47.

Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Aitmokhtar O, Paganelli F, Benamara S, Azaza A, Bonello L, Hamza O, Seddiki S, Benathmane T, Saidane M, Bouzid A, Kara M, Sik A, Azzouz A, Harbi F, Monsuez JJ, Benkhedda S.

Arch Cardiovasc Dis. 2017 Nov;110(11):626-633. doi: 10.1016/j.acvd.2016.12.017. Epub 2017 Jun 2.

48.

Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation.

Peyrol M, Barraud J, Cautela J, Maille B, Laine M, Bonello L, Thuny F, Paganelli F, Franceschi F, Koutbi L, Levy S.

J Interv Card Electrophysiol. 2017 Aug;49(2):191-196. doi: 10.1007/s10840-017-0255-5. Epub 2017 May 23.

PMID:
28536837
49.

Diagnostic accuracy of surface coil MRI in assessing cartilaginous invasion in laryngeal tumours: Do we need contrast-agent administration?

Preda L, Conte G, Bonello L, Giannitto C, Tagliabue E, Raimondi S, Ansarin M, De Benedetto L, Cattaneo A, Maffini F, Bellomi M.

Eur Radiol. 2017 Nov;27(11):4690-4698. doi: 10.1007/s00330-017-4840-x. Epub 2017 May 5.

PMID:
28477165
50.

Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation: comment.

Bonello L, Laine M, Camoin-Jau L, Frere C.

J Thromb Haemost. 2017 Jul;15(7):1522-1523. doi: 10.1111/jth.13705. Epub 2017 May 22. No abstract available.

Supplemental Content

Loading ...
Support Center